• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Lonny Reisman Previews His PCDC Keynote

Video

There are 2 dimensions to patient centeredness of diabetes care that Lonny Reisman, MD, the founder and chief executive officer of HealthReveal, will focus on during his keynote speech at Patient-Centered Diabetes Care 2016.

There are 2 dimensions to patient centeredness of diabetes care that Lonny Reisman, MD, the founder and chief executive officer of HealthReveal, will focus on during his keynote speech at Patient-Centered Diabetes Care 2016. To learn more about the conference and register now, click here.

Transcript (slightly modified)

As the keynote speaker for Patient-Centered Diabetes Care 2016, what will be the focus of your presentation?

I'm very excited about the Patient-Centered Diabetes Care symposium. I think the first thing that I will focus on relates to the need for patient centeredness when we're dealing with specific disease states like diabetes. And I think there are 2 dimensions to patient centeredness that I would like to focus on. One is a physiologic or clinical perspective, which not only relates to diabetes and sugar control but in a more holistic and comprehensive way the other components of diabetes management that relate to comorbidities and complications that can occur in a diabetic. So issues like lipid control, blood pressure control, smoking, activity and exercise, which fundamentally can alter the well-being of a diabetic patient.

The other dimension, I think, relates to the behaviors and engagement of the particular patient. So from a clinical perspective we can access the best evidence and the best technologies to define an optimal clinical path for a patient. Having said that, if the patient doesn't adequately engage and adhere to it, then all of our efforts are really for nothing. So I think there's a real need from a behavioral economist's perspective to make sure that patients are engaged and are complying with the guidance that we can generate on the clinical side.

Related Videos
Pat Van Burkleo
Jeff Stark, MD, vice president, head of medical immunology, UCB
Robert Groves, MD
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Dr Padma Sripada, Columbia Internal Medicine
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
dr amy paller
Shawn Kwatra, MD, dermatologist, John Hopkins University
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.